Target intelligence / Profile preview

Glycosaminoglycan biosynthesis enzymes (GAG biosynthesis enzymes)

Target
GAG biosynthesis enzymes
Molecular classification
Enzyme, Glycosyltransferase, Sulfotransferase, Epimerase
01

Overview

Glycosaminoglycan (GAG) biosynthesis enzymes comprise a diverse set of Golgi-resident proteins, including xylosyltransferases, galactosyltransferases, and various glycosyltransferases (e.g., EXT1, EXT2, CHSY1) that assemble long, unbranched polysaccharide chains [1][2]. These enzymes are responsible for the production of essential molecules like heparan sulfate, chondroitin sulfate, and dermatan sulfate, which are critical for extracellular matrix (ECM) integrity and the regulation of growth factor signaling [3]. Genetic mutations in these biosynthetic pathways result in a spectrum of disorders known as mucopolysaccharidoses (MPS) and skeletal dysplasias, characterized by the toxic accumulation of GAG precursors or structural defects in connective tissue [4]. In the context of cancer, these enzymes are often upregulated, facilitating tumor growth and metastasis by altering the tumor microenvironment [5]. Therapeutic targeting of this pathway includes substrate reduction therapies, such as the use of Odiparcil, which acts as a decoy substrate to reduce the synthesis of pathological GAGs in MPS patients [6]. Additionally, small molecule inhibitors targeting specific sulfotransferases are being explored to modulate inflammatory responses and viral entry, as many pathogens utilize surface GAGs for host cell attachment [7]. Sources: [1] KEGG Pathway map00532/map00534; [2] UniProt Glycosyltransferase family; [3] Nature (2007) 446:1030-1037; [4] Mol Genet Metab (2021) 132:S1; [5] FEBS J (2012) 279:1177-1197; [6] Inventiva Pharma Pipeline; [7] Antiviral Res (2004) 64:1-10.

Other names
Glycan biosynthesis pathway enzymesGAG biosynthetic enzymesGlycosaminoglycan metabolic enzymesHeparan sulfate/Chondroitin sulfate biosynthesis enzymes
02

Mechanism of action

Substrate reduction therapy (SRT) through the use of decoy substrates to divert biosynthetic flux, and competitive inhibition of specific glycosyltransferases or sulfotransferases to modulate GAG chain length and sulfation patterns.

03

Biological functions

Glycan biosynthesisExtracellular matrix organizationCell signalingCell-cell interactionGrowth factor regulation
04

Disease associations

MucopolysaccharidosisCancerSkeletal dysplasiaInflammationViral infection
05

Safety considerations

Systemic disruption of extracellular matrix integritySkeletal growth impairmentPotential interference with endogenous anticoagulationOff-target effects on lysosomal function
06

Interacting drugs

Odiparcil

4 more in the full profile.

07

Biomarkers

Urinary glycosaminoglycansHeparan sulfate levelsDermatan sulfate levelsChondroitin sulfate levelsGAG disaccharide composition

Beyond the preview

Go deeper on Glycosaminoglycan biosynthesis enzymes (GAG biosynthesis enzymes).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycosaminoglycan biosynthesis enzymes (GAG biosynthesis enzymes).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call